BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1422 related articles for article (PubMed ID: 16757720)

  • 1. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial.
    Aoyama H; Shirato H; Tago M; Nakagawa K; Toyoda T; Hatano K; Kenjyo M; Oya N; Hirota S; Shioura H; Kunieda E; Inomata T; Hayakawa K; Katoh N; Kobashi G
    JAMA; 2006 Jun; 295(21):2483-91. PubMed ID: 16757720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial.
    Brown PD; Jaeckle K; Ballman KV; Farace E; Cerhan JH; Anderson SK; Carrero XW; Barker FG; Deming R; Burri SH; Ménard C; Chung C; Stieber VW; Pollock BE; Galanis E; Buckner JC; Asher AL
    JAMA; 2016 Jul; 316(4):401-409. PubMed ID: 27458945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.
    Chang EL; Wefel JS; Hess KR; Allen PK; Lang FF; Kornguth DG; Arbuckle RB; Swint JM; Shiu AS; Maor MH; Meyers CA
    Lancet Oncol; 2009 Nov; 10(11):1037-44. PubMed ID: 19801201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases: Secondary Analysis of the JROSG 99-1 Randomized Clinical Trial.
    Aoyama H; Tago M; Shirato H;
    JAMA Oncol; 2015 Jul; 1(4):457-64. PubMed ID: 26181254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
    Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
    J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Large Brain Metastases With Stereotactic Radiosurgery.
    Zimmerman AL; Murphy ES; Suh JH; Vogelbaum MA; Barnett GH; Angelov L; Ahluwalia M; Reddy CA; Chao ST
    Technol Cancer Res Treat; 2016 Feb; 15(1):186-95. PubMed ID: 25633136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases.
    Chidel MA; Suh JH; Reddy CA; Chao ST; Lundbeck MF; Barnett GH
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):993-9. PubMed ID: 10863070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases.
    Patil CG; Pricola K; Sarmiento JM; Garg SK; Bryant A; Black KL
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD006121. PubMed ID: 22972090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases.
    Patil CG; Pricola K; Sarmiento JM; Garg SK; Bryant A; Black KL
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD006121. PubMed ID: 28945270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone.
    Aoyama H; Tago M; Kato N; Toyoda T; Kenjyo M; Hirota S; Shioura H; Inomata T; Kunieda E; Hayakawa K; Nakagawa K; Kobashi G; Shirato H
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1388-95. PubMed ID: 17674975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases.
    Patil CG; Pricola K; Garg SK; Bryant A; Black KL
    Cochrane Database Syst Rev; 2010 Jun; (6):CD006121. PubMed ID: 20556764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases.
    Kondziolka D; Patel A; Lunsford LD; Kassam A; Flickinger JC
    Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):427-34. PubMed ID: 10487566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage whole brain radiotherapy or stereotactic radiosurgery after initial stereotactic radiosurgery for 1-4 brain metastases.
    Liu Y; Alexander BM; Chen YH; Horvath MC; Aizer AA; Claus EB; Dunn IF; Golby AJ; Johnson MD; Friesen S; Mannarino EG; Wagar M; Hacker FL; Arvold ND
    J Neurooncol; 2015 Sep; 124(3):429-37. PubMed ID: 26108659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage stereotactic radiosurgery effectively treats recurrences from whole-brain radiation therapy.
    Chao ST; Barnett GH; Vogelbaum MA; Angelov L; Weil RJ; Neyman G; Reuther AM; Suh JH
    Cancer; 2008 Oct; 113(8):2198-204. PubMed ID: 18780319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for up to 10 brain metastases.
    Lester-Coll NH; Dosoretz AP; Magnuson WJ; Laurans MS; Chiang VL; Yu JB
    J Neurosurg; 2016 Dec; 125(Suppl 1):18-25. PubMed ID: 27903191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy.
    Sanghvi SM; Lischalk JW; Cai L; Collins S; Nair M; Collins B; Unger K
    Radiat Oncol; 2017 Feb; 12(1):43. PubMed ID: 28245881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes of stereotactic radiosurgery in the treatment of patients with metastatic brain tumors.
    Elaimy AL; Mackay AR; Lamoreaux WT; Fairbanks RK; Demakas JJ; Cooke BS; Lee CM
    World Neurosurg; 2011; 75(5-6):673-83. PubMed ID: 21704935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.
    Brown PD; Ballman KV; Cerhan JH; Anderson SK; Carrero XW; Whitton AC; Greenspoon J; Parney IF; Laack NNI; Ashman JB; Bahary JP; Hadjipanayis CG; Urbanic JJ; Barker FG; Farace E; Khuntia D; Giannini C; Buckner JC; Galanis E; Roberge D
    Lancet Oncol; 2017 Aug; 18(8):1049-1060. PubMed ID: 28687377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative stereotactic radiosurgery without whole-brain radiation therapy for brain metastases: potential role of preoperative tumor size.
    Hartford AC; Paravati AJ; Spire WJ; Li Z; Jarvis LA; Fadul CE; Rhodes CH; Erkmen K; Friedman J; Gladstone DJ; Hug EB; Roberts DW; Simmons NE
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):650-5. PubMed ID: 22795806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of whole-brain radiation therapy after stereotactic radiation surgery for brain metastases.
    Hasan S; Shah AH; Bregy A; Albert T; Markoe A; Stoyanova R; Thambuswamy M; Komotar RJ
    Pract Radiat Oncol; 2014; 4(5):306-315. PubMed ID: 25194099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 72.